Smigielski, Lukasz http://orcid.org/0000-0002-7428-7644
Papiol, Sergi http://orcid.org/0000-0001-9366-8728
Theodoridou, Anastasia http://orcid.org/0000-0003-4792-385X
Heekeren, Karsten
Gerstenberg, Miriam
Wotruba, Diana
Buechler, Roman
Hoffmann, Per
Herms, Stefan http://orcid.org/0000-0002-2786-8200
Adorjan, Kristina
Anderson-Schmidt, Heike
Budde, Monika http://orcid.org/0000-0001-7301-9157
Comes, Ashley L. http://orcid.org/0000-0001-6745-9834
Gade, Katrin
Heilbronner, Maria
Heilbronner, Urs http://orcid.org/0000-0001-7135-762X
Kalman, Janos L. http://orcid.org/0000-0003-0930-4214
Klöhn-Saghatolislam, Farahnaz
Reich-Erkelenz, Daniela
Schaupp, Sabrina K.
Schulte, Eva C.
Senner, Fanny
Anghelescu, Ion-George
Arolt, Volker
Baune, Bernhard T.
Dannlowski, Udo http://orcid.org/0000-0002-0623-3759
Dietrich, Detlef E.
Fallgatter, Andreas J.
Figge, Christian
Jäger, Markus
Juckel, Georg
Konrad, Carsten http://orcid.org/0000-0001-7015-3860
Nieratschker, Vanessa http://orcid.org/0000-0001-7884-4500
Reimer, Jens
Reininghaus, Eva http://orcid.org/0000-0001-5964-4087
Schmauß, Max
Spitzer, Carsten
von Hagen, Martin
Wiltfang, Jens http://orcid.org/0000-0003-1492-5330
Zimmermann, Jörg
Gryaznova, Anna
Flatau-Nagel, Laura
Reitt, Markus
Meyers, Milena
Emons, Barbara
Haußleiter, Ida Sybille
Lang, Fabian U.
Becker, Thomas
Wigand, Moritz E.
Witt, Stephanie H. http://orcid.org/0000-0002-1571-1468
Degenhardt, Franziska
Forstner, Andreas J. http://orcid.org/0000-0002-1876-6368
Rietschel, Marcella http://orcid.org/0000-0002-5236-6149
Nöthen, Markus M.
Andlauer, Till F. M. http://orcid.org/0000-0002-2917-5889
Rössler, Wulf
Walitza, Susanne
Falkai, Peter
Schulze, Thomas G.
Grünblatt, Edna http://orcid.org/0000-0001-8505-7265
Article History
Received: 27 August 2021
Revised: 24 October 2021
Accepted: 29 October 2021
First Online: 26 November 2021
Competing interests
: VA has received personal fees from Janssen Pharmaceuticals, AstraZeneca, Lundbeck, Sanofi, and Servier Laboratories. PF has received research support and honorarium for lectures or advisory activity from Abbott Laboratories, Boehringer Ingelheim, Janssen Pharmaceuticals, Essex Pharma, Lundbeck, Otsuka Pharmaceutical, Recordati, Richter Pharma, Servier Laboratories, and Takeda. CK has received personal fees from Aristo Pharmaceuticals, Janssen-Cilag, Eli Lilly and Company, MagVenture, Trommsdorff GmbH, Lundbeck, Neuraxpharm, and Servier Laboratories. MMN has received personal fees from the Lundbeck Foundation, the Robert-Bosch-Stiftung, HMG Systems Engineering GmbH, and Shire Deutschland GmbH. He receives salary payments from Life & Brain GmbH and holds shares in Life & Brain GmbH. JR has received personal fees from Lundbeck and Otsuka Pharmaceutical. MS has received personal fees for being a member of the speaker’s bureau and advisory board from Aristo Pharmaceuticals, Janssen-Cilag, Lundbeck, Neuraxpharm, and Recordati. SW has received royalties from Thieme Hogrefe, Kohlhammer, Springer, and Beltz and lecture honoraria from Opopharma in the past 5 years. JW has received grants from the German Research Foundation and personal fees from Abbott Laboratories, Boehringer Ingelheim, Immungenetics, Eli Lilly and Company, MSD Sharp & Dohme, Roche, Actelion, Amgen, Janssen-Cilag, Pfizer, and Med Update and has patents PCT/EP 2011001724 and PCT/EP 2015052945 issued. The other authors declare no biomedical financial interests or potential conflicts of interest.